# reload+after+2024-01-23 11:44:19.350054
address1§128 Spring Street
address2§Building A Suite 510
city§Lexington
state§MA
zip§02421
country§United States
phone§857 285 4140
website§https://cyteir.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. Cyteir Therapeutics, Inc. was incorporated in 2012 and is headquartered in Lexington, Massachusetts.
fullTimeEmployees§46
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Joseph S. Zakrzewski', 'age': 61, 'title': 'Independent Investor & Independent Chairman of the Board', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 81500, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Markus F. Renschler M.D.', 'age': 62, 'title': 'President, CEO & Director', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 718620, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kevin  Mills Ph.D.', 'title': 'Co-Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David G. Gaiero', 'age': 45, 'title': 'CFO & Treasurer', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': "Dr. Tom  O'Shea Ph.D.", 'title': 'Senior Vice President of Clinical Pharmacology & Preclinical Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Krisztina  Nemenyi Ph.D.', 'title': 'Senior Vice President of Regulatory Affairs and Quality', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.069
currency§USD
dateShortInterest§1702598400
forwardEps§-0.87
exchange§NMS
quoteType§EQUITY
shortName§Cyteir Therapeutics, Inc.
longName§Cyteir Therapeutics, Inc.
firstTradeDateEpochUtc§1624023000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§fe3971ec-1a5e-36ca-8d47-68e4e988de27
gmtOffSetMilliseconds§-18000000
targetHighPrice§3.0
targetLowPrice§3.0
targetMeanPrice§3.0
targetMedianPrice§3.0
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§21.655
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
